Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...
Four medicines received positive opinions from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) last week, expanding treatment options for cancer, rare ...
Please provide your email address to receive an email when new articles are posted on . Results showed use of IV vancomycin was linked with a higher periprosthetic joint infection risk vs. use of ...
Clinicians should treat ventilator‑associated pneumonia (VAP) until the infection is controlled and the patient is clearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results